Use of a population pharmacokinetic approach for the clinical development of a fixed-dose subcutaneous formulation of trastuzumab.

CPT Pharmacometrics Syst Pharmacol · 2014 · PMC3910009 · PMID 25019376

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a small trendno p-value reported

Although this model described the data adequately, it showed a small trend for overpredicting trastuzumab serum levels at low concentrations.

also in 722 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.